Susan Richards Windham Bannister Aridis Pharmaceuticals, Inc. (ARDS) insider trading activity

ARDS Quotes by TradingView

Susan Richards Windham Bannister is Director of Aridis Pharmaceuticals, Inc.. Currently has a direct ownership of 5,000 shares of ARDS, which is worth approximately $0. The most recent transaction as insider was on Jun 05, 2023, when has been sold 5,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5K
0% 3M change
0% 12M change
Total Value Held $0

Susan Richards Windham-Bannister Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 05 2023
BUY
Exercise of conversion of derivative security
-
5,000 Added 50.0%
5,000 Common Stock

Also insider at

HSTO
Histogen Inc. Healthcare
Director
HUMA
Humacyte, Inc. Healthcare
Director
SRW

Susan Richards Windham Bannister

Director
San Diego, CA

Track Institutional and Insider Activities on ARDS

Follow Aridis Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARDS shares.

Notify only if

Insider Trading

Get notified when an Aridis Pharmaceuticals, Inc. insider buys or sells ARDS shares.

Notify only if

News

Receive news related to Aridis Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ARDS